Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)

Active
Yes
Status
Posted
Published Date
April 5th, 2024
Close Date
July 22nd, 2024
Opportunity No.
RFA-TR-24-021

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Public and State Controlled Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) is seeking a single source for the continuation of the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Network (RDCRN). This funding opportunity aims to support the DMCC at Cincinnati Children's Hospital Medical Center (CCHMC). The RDCRN is focused on advancing and improving the diagnosis, management, and treatment of various rare diseases through collaborative, multi-site, patient-centric research. The DMCC plays a crucial role in facilitating and supporting the activities of individual Rare Diseases Clinical Research Consortia (RDCRCs) as well as trans-network activities. It provides administrative support, data management support, clinical research support, patient engagement, and broad dissemination of information. The ultimate goal is to enhance rare disease research by identifying individuals with rare diseases early on and ensuring clinical trial readiness. This funding opportunity is non-competitive and intends to fund a single award. The grant does not require cost sharing or matching. Public and State Controlled Institutions of Higher Education are eligible to apply. Non-domestic entities and components of U.S. organizations are not eligible to apply. The deadline for application submission is July 22, 2024. For more information and to apply, please visit the following link: Additional Information. If you have any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Description

This is a non-competitive funding opportunity intended to fund a single award. NCATS is announcing its intent to issue a single source cooperative agreement to Cincinnati Childrens Hospital Medical Center (CCHMC) to support the Data Management and Coordinating Center. The Rare Diseases Clinical Research Network (RDCRN) is intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research with an emphasis on early and timely identification of individuals with rare diseases and clinical trial readiness. The DMCC facilitates and supports the activities of each individual Rare Diseases Clinical Research Consortium (RDCRC) along with trans-network activities that broadly facilitate the advancement of rare disease research via four avenues: administrative support, data management support, clinical research support and patient engagement, and broad dissemination of information. The RDCRCs will continue conducting research conducted under a separate NOFO.

Contact Information

Attachments
195 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Data Management and Coordinating Center (DMCC) for the Rare Diseases Clinical Research Network (RDCRN). The DMCC will support the activities of the Rare Diseases Clinical Research Consortia (RDCRC) and facilitate the advancement of rare disease research. This FOA is expected to be published in 2024, with an estimated award date in 2025. The DMCC will play a crucial role in advancing the diagnosis, management, and treatment of rare diseases through collaborative, translational, and clinical research. The FOA will utilize the U2C activity code and will provide funding of approximately $1,000,000. Potential applicants are encouraged to develop meaningful collaborations and responsive projects. For more information, please contact Tiina K. Urv, Ph.D. at urvtiin@mail.nih.gov or 301-827-2746.
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)". This grant aims to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The objective of this grant is to advance and improve the diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness. The grant does not require cost sharing or matching requirements and falls under the category of Income Security and Social Services. The maximum award ceiling is $1,000,000. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are also not eligible to apply. The grant opportunity will close on August 13, 2024, and the archive date is set for September 18, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-206.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Notice of Intent to Publish a Funding Opportunity Announcement for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) for the Rare Diseases Clinical Research Consortia (RDCRC) in the Rare Diseases Clinical Research Network (RDCRN). This funding opportunity aims to advance the diagnosis, management, and treatment of rare diseases. The RDCRC will support highly collaborative, multi-site, patient-centric, translational, and clinical research. It is encouraged that the RDCRC study outcome measures address unmet clinical trial readiness needs to advance the field of research. Potential applicants are provided with sufficient time to develop collaborations and projects. The FOA is expected to be published in 2024, with an application due date in 2024. The funding will be provided through cooperative agreement awards utilizing the U54 activity code. For more information, contact Tiina K. Urv, Ph.D. at urvtiin@mail.nih.gov or 301-827-2746.
Notice of Intent to Publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN)
National Institutes of Health
The National Institutes of Health (NIH) plans to publish a Notice of Funding Opportunity (NOFO) for the Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN). This NOFO aims to solicit applications for research that will advance the diagnosis, management, and treatment of rare diseases. The RDCRC will facilitate collaborative, multi-site, patient-centric, translational, and clinical research. It is encouraged that the RDCRC study outcome measures address unmet clinical trial readiness needs to propel the field of research forward. Potential applicants are provided with sufficient time to develop collaborations and projects. The NOFO is expected to be published in winter 2024, with an application due date in summer 2024. The funding will be in the form of a Cooperative Agreement, and there is no cost sharing or matching requirement. The estimated total program funding is $1,000,000. The NOFO will utilize the U54 activity code, which supports specialized centers through multi-project cooperative agreement awards with substantial involvement from NIH program staff. The estimated synopsis post date is January 24, 2024, and the estimated synopsis close date is June 14, 2024. The estimated award date and project start date are both July 1, 2025.